Replies to post #16028 on Intellect Neurosciences Inc. (fka ILNS)

[Profit]

absolutely strange, but not sre yet what to read into it other than no pressure earlier post

[itwillgetbetter]

well if that's the answer to shareholder concerns I eat my hat.

Reading into todays pr which to me was a complete waste of ink time and money imo cause if you invested into Intellect and do not understand this ongoing trial with shire is a make or break for ILNS its shareholders you sure got holes in your DD.

What puzzles me he has a complete list of shareholder concers not just what I emailed in but since that july 31 pr how many emails question do you think they got.No telling how many and we get this.

Get out of here.

[tencoin]

If we read well between the words, and if we consider the enthusiasm of Mr. Maza to write a detailed letter to shareholders, we can believe that we already had in place an agreement with Shire Pharma for a merger.

Probably, the merger agreement is taking place at this time with AbbVie Pharma ...

However, something very good is brewing because Mr. Maza has left out important topics for us ... probably these updates have become small details with little meaning ...








































.,

[mkaiz]

All he did was tell us something we already new what reason would you do that